UK-based campaigns on global justice and development in the Global South
The UK‑US trade deal on medicines has prompted warnings after a BMJ analysis shows that diverting NHS funds to pay higher drug prices could cause up to 229,000 excess deaths by 2036, rising to 291,000 when social care is included.
The UK and US have finalized a medicines partnership allowing British drug exports to avoid US tariffs and increasing NHS drug spending. Critics warn it risks NHS funding and transparency, while supporters highlight potential benefits for patients and the UK economy. The deal's details remain partly secret, raising concerns about oversight.